Literature DB >> 16327668

[Sciatic lesions associated with hip surgery].

A Lädermann1, D Ceroni, M Magistris, P Hoffmeyer.   

Abstract

PURPOSE OF THE STUDY: The incidence of neurological lesions after hip surgery is underestimated because of variable clinical expression and functional disorders resulting from nerve injury and often considered to be the normal course after hip surgery. The incidence of nerve lesions after hip surgery for fractures of the proximal femur remains to be detailed. MATERIAL AND
METHOD: This retrospective study included 20 cases of sciatic nerve injury following hip surgery (2554 THA, 394 revision THA, 4632 osteosyntheses or hemiarthroplasties of the proximal femur). We noted degree of recovery of the neurological deficit and deterioration of the patients' quality-of-life. The prognosis was determined on the basis of clinical and electromyographic data.
RESULTS: The incidence of nerve injury after hip surgery was 0.5% after THA, 1% after revision THA, and 0.08% after osteosynthesis or hemiarthroplasty of the proximal femur. The etiological factor remained unknown in the majority of the cases. The prognosis was tightly related to the type of neurological lesion as defined by the electrophysiological study. Three revision procedures were performed: two for drainage of a compressive hematoma and one to release the sciatic nerve (neurolysis). The prognosis depended on the type of neurological lesion as established by the electroneuromyographic study. DISCUSSION: Severe axonotmesis is associated with late recovery, generally incomplete recovery, and poor long-term functional outcome.

Entities:  

Mesh:

Year:  2005        PMID: 16327668     DOI: 10.1016/s0035-1040(05)84467-8

Source DB:  PubMed          Journal:  Rev Chir Orthop Reparatrice Appar Mot        ISSN: 0035-1040


  1 in total

Review 1.  Radiological changes, infections and neurological complications after reverse shoulder arthroplasty related to different design types and their rates: Part II.

Authors:  Marko Nabergoj; Patrick J Denard; Philippe Collin; Rihard Trebše; Alexandre Lädermann
Journal:  EFORT Open Rev       Date:  2021-11-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.